Abstract: The present invention discloses polynucleotides which identify and encode DP119, DP444, DP810, DP685, WE474, DP160, RA977, or RA770 as well as novel functions for these proteins of the inventions. The invention provides for compositions for disorders associated with the expression of the proteins of the invention, such as for the treatment, alleviation and/or prevention of pancreatic dysfunction (for example diabetes, hyperglycemia, and impaired glucose tolerance), and related disorders, and other disease and disorders.
Abstract: The present invention discloses proteins regulating the energy homeostasis and the metabolism of triglycerides, and polynucleotides, which identify and encode the proteins disclosed in this invention. The invention also relates to the use of these sequences in the diagnosis, study, prevention and treatment of metabolic diseases and disorders.
Abstract: The invention relates to the ovine embryo cell line HVO-156 (DSM ACC2440), or to cell lines derived therefrom, and to their use for preparing and propagating ovine adenoviruses, in particular recombinant ovine adenoviruses which are derived from the isolate OAV 287.
Type:
Grant
Filed:
July 15, 2002
Date of Patent:
November 23, 2004
Assignee:
DeveloGen Aktiengesellschaft für entwicklungsbiologische
Forschung
Inventors:
Christian Hofmann, Moritz Hillgenberg, Peter Löser